Shamrock Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$135K Buy
3,970
+705
+22% +$25.6K 0.11% 96
2019
Q2
$134K Sell
3,265
-378
-10% -$15K 0.09% 104
2019
Q1
$147K Sell
3,643
-1,859
-34% -$74.4K 0.12% 93
2018
Q4
$228K Buy
5,502
+3
+0.1% +$125 0.34% 66
2018
Q3
$230K Buy
5,499
+2
+0% +$77 0.15% 95
2018
Q2
$189K Sell
5,497
-144
-3% -$4.92K 0.12% 107
2018
Q1
$191K Buy
5,641
+3
+0.1% +$103 0.11% 106
2017
Q4
$194K Buy
5,638
+3
+0.1% +$102 0.12% 98
2017
Q3
$191K Sell
5,635
-415
-7% -$13.3K 0.12% 93
2017
Q2
$193K Sell
6,050
-821
-12% -$25.9K 0.12% 100
2017
Q1
$223K Sell
6,871
-418
-6% -$13.2K 0.14% 96
2016
Q4
$225K Buy
7,289
+960
+15% +$29.3K 0.14% 94
2016
Q3
$203K Buy
6,329
+3,172
+100% +$106K 0.12% 96
2016
Q2
$105K Buy
3,157
+2,644
+515% +$84.4K 0.06% 116
2016
Q1
$14K Hold
513
0.01% 200
2015
Q4
$16K Hold
513
0.01% 202
2015
Q3
$15K Hold
513
0.01% 194
2015
Q2
$16K Hold
513
0.01% 196
2015
Q1
$17K Hold
513
0.01% 205
2014
Q4
$15K Hold
513
0.01% 178
2014
Q3
$14K Hold
513
0.01% 197
2014
Q2
$14K Hold
513
﹤0.01% 224
2014
Q1
$16K Buy
+513
New +$15.3K 0.01% 218

Other funds holding PFE

Shamrock Asset Management's PFE Position: Q3 2019 in Review

Shamrock Asset Management increased its Pfizer (PFE) stake by 22% in Q3 2019, buying an estimated $25.6K and bringing the position to 3,970 shares worth $135K. The position accounts for 0.11% of the portfolio, ranked #96.

Shamrock Asset Management first reported a position in PFE in Q1 2014 and has held it in 23 quarters since. The position peaked at $230K in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Shamrock Asset Management held 3,970 shares of Pfizer worth $135K as of Q3 2019.
  • Shamrock Asset Management bought 705 Pfizer shares in Q3 2019, an estimated $25.6K.
  • Pfizer made up 0.11% of Shamrock Asset Management's portfolio in Q3 2019, its #96 holding.
  • Shamrock Asset Management first reported a position in Pfizer in Q1 2014 and has held it in 23 quarters since.
  • Shamrock Asset Management's Pfizer position peaked at $230K in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.